ロード中...
Bispecific Antibodies in the Treatment of Hematologic Malignancies
Monoclonal antibody therapies are an important approach for the treatment of hematologic malignancies, but typically show low single‐agent activity. Bispecific antibodies, however, redirect immune cells to the tumor for subsequent lysis, and preclinical and accruing clinical data support single‐agen...
保存先:
| 出版年: | Clin Pharmacol Ther |
|---|---|
| 主要な著者: | , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
John Wiley and Sons Inc.
2019
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6766786/ https://ncbi.nlm.nih.gov/pubmed/30770546 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cpt.1396 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|